Inside the research
Doximity, Inc.
DOCS Research profile · latest available data
Price overview
$26.35
▲ +0.31 (+1.2%)
| 52w hi | $75.12 |
|---|---|
| 52w lo | $18.01 |
| Vol | 2.01M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.18
| Short | -0.27 |
|---|---|
| Medium | -0.10 |
| Long | -0.13 |
computed 2026-09-27
Key fundamentals
Doximity, Inc.
Healthcare · Health Information Services
| Market cap | $4.70B |
|---|---|
| Enterprise value | $4.02B |
| Trailing P/E | 31.37x |
| Forward P/E | 17.01x |
| EV / EBITDA | 19.28x |
| P / S (ttm) | 7.16x |
| Profit margin | 25.5% |
| Return on equity | 17.2% |
| Revenue growth | +7.3% |
| Earnings growth | -51.9% |
| Debt / equity | 1.06 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.12 | |
| Sector | +0.08 | |
| Technical | -0.20 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Risk Metrics
| Beta vs SPX | 1.09 |
|---|---|
| Corr SPX | 0.26 |
| Annual vol | 66.0% |
| Annual ret | -1.3% |
| Sharpe | -0.02 |
| Max DD | -78.3% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Exhibits | read |
| 2026-05-13 | Earnings Release, Officer / Director Change… | read |
| 2026-04-17 | Officer / Director Change, Reg FD Disclosure | read |
| 2026-02-05 | Earnings Release, Officer / Director Change… | read |
| 2025-12-30 | Other Material Event | read |
| 2025-11-06 | Earnings Release, Exhibits | read |
| 2025-09-02 | Shareholder Vote | read |
| 2025-08-15 | Officer / Director Change | read |
| 2025-08-07 | Earnings Release, Exhibits | read |
| 2025-06-13 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-05-15 | Earnings Release, Exhibits | read |
| 2025-02-06 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Cabral Timothy S | C | 7.50K | — | |
| 2026-08-07 | Cabral Timothy S | Sell | 7.50K | $293.32K | |
| 2026-07-15 | Sitaram Siddharth | Chief Accounting Officer | C | 4.80K | — |
| 2026-07-15 | Sitaram Siddharth | Chief Accounting Officer | Sell | 1.73K | $38.14K |
| 2026-07-13 | Benjamin Regina M. | Grant | 21.31K | — | |
| 2026-05-11 | Sitaram Siddharth | Interim PFO and PAO | C | 5.00K | — |
| 2026-05-11 | Sitaram Siddharth | Interim PFO and PAO | Sell | 2.31K | $59.50K |
Flow & Concentration
| Insider 180d net | -$390.97K |
|---|---|
| Insider buys / sells | 0 / 3 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 92.4% |
| HHI | 1,930 (moderate) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $87.33M | 4.21M |
| Renaissance Technologies | $59.18M | 2.85M |
| Citadel Advisors | $46.43M | 2.24M |
| Millennium Management | $42.90M | 2.07M |
| AQR Capital Management | $37.86M | 1.84M |
| Capital Research / Capital World | $18.87M | 909.76K |
| Bridgewater Associates | $2.73M | 131.45K |
| Fidelity / FMR LLC | $764.32K | 36.85K |
| T. Rowe Price Group | $2.71K | 130.43K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2022–2025 · 4 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $570.40M | +18.4% | |
| Gross profit | $424.75M | +61.2% | |
| Operating income | $125.11M | +3.3% | |
| Net income | $112.82M | +56.0% | |
| Cash from ops | $184.10M | +13.3% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $25.93 | $26.62 | $25.72 | $26.35 | 2.01M |
| Sep 24 | $26.47 | $26.96 | $26.03 | $26.04 | 2.47M |
| Sep 23 | $26.64 | $27.00 | $26.34 | $26.57 | 2.47M |
| Sep 22 | $27.27 | $27.48 | $26.23 | $26.51 | 2.41M |
| Sep 21 | $26.50 | $26.86 | $26.30 | $26.84 | 2.62M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →